Dr. Peter T. Lin, MD

Dr. Lin practices at Santa Clara Valley Medical Center in San Jose, California, part of County of Santa Clara, CA.

Dr. Lin's NPI, 1780871186, was assigned on September 29, 2007. Dr. Lin graduated from University Of Michigan Medical School in 2001. Dr. Lin holds California license A79891.

Dr. Lin's primary practice is Santa Clara Valley Medical Center, at 751 South Bascom Avenue, San Jose, CA 95128 in Santa Clara County. The practice phone is (408) 885-5000.

Dr. Lin's primary practice is Santa Clara Valley Medical Center in San Jose, California, part of County of Santa Clara, CA. Dr. Lin is also affiliated with El Camino Health - Mountain View Hospital. The medical group on file is County of Santa Clara Behavioral Health Services, Las Plumas Behavioral Health Clinic. Dmand AI also links Dr. Lin to 1 more community health center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Lin is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Lin is licensed in California.

Dmand AI lists essential tremor, fibromyalgia and chronic pain, migraine and chronic headache, mobility impairment, non-alzheimer's dementia (chronic), parkinson's disease, restless legs syndrome and thoracic spine disorders among the conditions Dr. Lin treats.

CMS data shows 23,248 Medicare services from Dr. Lin across 13 procedure codes in 2024, for 266 Medicare patients. Medicare paid $242,330 for them. Every service was in an office.

CMS counts 266 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 107 patients. 70% of them have high cholesterol, and 68% have parkinson's disease. 18% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 68, with 53% women.

In 2024, Dr. Lin wrote 4,107 Medicare Part D claims for 391 patients. 80% of them were for generic drugs. CMS names the drug for 3,837 of them, across 57 drugs with 11 or more claims each, at $1,403,775 in total drug cost. In 2023, CMS named 4,430 claims across 64 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Lin for performance year 2024, reported individually.

Dmand AI links 46 papers to Dr. Lin, published from 2007 to 2022. 2009 was the busiest year, with 7. The most frequent topics are Movement, Electroencephalography and Brain Mapping. Dr. Lin has published most often in Clin Neurophysiol. Dr. Lin's most frequent co-authors are Joseph Gerard Gleeson, MD, Mitchel S. Berger, MD and Sally Borucki, MD.

Dmand AI links Dr. Lin to 2 clinical trials. Conditions studied include Delusions and Hallucinations. ACADIA Pharmaceuticals Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Lin that name 1 trial.

CMS Open Payments shows 1,259 general payments to Dr. Lin from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. MDD US Operations, LLC paid the most, $8,457. It also lists 7 research payments totaling $50,730 from 2019 to 2023, naming 1 clinical trial.

Dmand AI lists 11 awards for Dr. Lin, most recently Special Commendation for Teaching Excellence in 2015.

Dr. Lin graduated from University Of Michigan Medical School in 2001. Dr. Lin is a member of AOA, AAN and MDS.

Dr. Lin is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.